Daven Patel, CEO & Dr. Anand Srivastava, Chairman and Cofounder at Global Institute of Stem Cell Therapy and Research (GIOSTAR)

LATAM Medtech Leaders

Mr. Deven Patel, the CEO, President, and Cofounder of Global Institute of Stem Cell Therapy and Research (GIOSTAR) with headquarter in San Diego, California, U.S.A. GIOSTAR was formed with the vision to provide affordable stem cell-based therapies to the masses around the world suffering from degenerative or genetic diseases and unable to afford today’s high cost of treatment. Mr. Patel has served as the CEO, President, and Board of Directors in highly comprehensive industries such as Healthcare, Stem Cell Research, Architectural, General Construction, Alternative Energy, and Multifaceted Internet industries. Mr. Patel has served as the President of Federation of India Associations San Diego (FIA-SD) Mr. Patel has also served in key positions of several public and private organizations such as GIOSTAR Foundation, Asian and Pacific American Coalition (APAC), Asian Business Association, Cambridge Companies, Reality Changers, Global Organization of People of Indian Origin. He has also served as Vice President of the newly formed San Diego United Lion’s Club. Mr. Patel has served as the founding President of the Asian and Pacific American Coalition (APAC) representing San Diego API communities from nine Asian countries and spearheaded its efforts in 2011 at San Diego City Hall to create the new 9th City Council District in the City of San Diego to be an Asian Pacific American influenced district, first time in the history of San Diego through the redistricting process.

Dr. Anand Srivastava has been associated with leading universities and research institutions in the USA. In affiliation with University of California San Diego Medical College (UCSD), University of California Irvine Medical College (UCI), Salk Research Institute, San Diego, Burnham Institute For Medical Research, San Diego, University of California Los Angeles Medical College (UCLA), USA has helped develop several research programs and has an extensive research experience in the field of stem cell which is documented by several publications in revered scientific journals. Dr. Anand Srivastava’s success has its root in his unique background of expertise in Stem cell biology, protein biochemistry, molecular biology, immunology, in utero transplantation of stem cells, tissue targeting, gene therapy, and clinical research. There are many scientists who can work in a narrowly defined field but few have the broad and multidisciplinary experience to carry out clinical research in a field as challenging as Stem cell biology, cancer, and gene therapy field. Dr. Anand Srivastava’s wide-spectrum expertise is rare in clinical research and perfectly crafted to fit ideally with the GIOSTAR projects for stem cell transplant, cancer, and gene therapy research.